Effect of gene therapy on visual function in Leber’s congenital amaurosis

Cited by (1,016)

Items 501–600 of 1,016

1. A Frameshift Mutation in Golden Retriever Dogs with Progressive Retinal Atrophy Endorses SLC4A3 as a Candidate Gene for Human Retinal Degenerations
   Louise M Downs, B. Wallin‐Håkanson, M. E. G. Boursnell, Stefan L. Marklund, Åke A. Hedhammar, Katarina Truvé, Louise Hübinette, Kerstin Lindblad‐Toh, Tomas F. Bergström, Cathryn S. Mellersh · 2011 · PLoS ONE
2. Systemic and local immune responses to intraocular AAV vector administration in non-human primates
   Ail, Divya, Ren, Duohao, Brazhnikova, Elena, Nouvel-Jaillard, Céline, Bertin, Stephane, Mirashrafi, Seyed Bagher, Fisson, Sylvain, Dalkara, Deniz · 2022 · Molecular Therapy - Methods & Clinical Development
3. Strategies to circumvent humoral immunity to adeno-associated viral vectors
   Tse, Longping V, Moller-Tank, Sven, Asokan, Aravind · 2015 · Expert Opinion on Biological Therapy
4. Safety and Biodistribution of an Equine Infectious Anemia Virus-Based Gene Therapy, RetinoStat ^® , for Age-Related Macular Degeneration
   Binley, Katie, Widdowson, Peter S., Kelleher, Michelle, de Belin, Jackie, Loader, Julie, Ferrige, Georgina, Carlucci, Marie, Esapa, Margaret, Chipchase, Daniel, Angell-Manning, Diana et al. · 2012 · Human Gene Therapy
5. Three‐Year Safety Results of SAR422459 (EIAV‐ABCA4) Gene Therapy in Patients With ABCA4‐Associated Stargardt Disease: An Open‐Label Dose‐Escalation Phase I/IIa Clinical Trial, Cohorts 1‐5
   Maria A. Parker, Laura R. Erker, Isabelle S. Audo, Dongseok Choi, Saddek Mohand‐Saïd, Kąstytis Šeštakauskas, Patrick Benoit, Terence Appelqvist, Melissa R. Krahmer, Caroline Ségaut-Prévost et al. · 2022 · American Journal of Ophthalmology
6. AAV-mediated Tyrosinase Gene Transfer Restores Melanogenesis and Retinal Function in a Model of Oculo-cutaneous Albinism Type I (OCA1)
   Annagiusi Gargiulo, Ciro Bonetti, Sandro Montefusco, Simona Neglia, Umberto Di Vicino, Elena Marrocco, Michele Della Corte, Luciano Domenici, Alberto Auricchio, Enrico Maria Surace · 2009 · Molecular Therapy
7. Vitamin A derivatives as treatment options for retinal degenerative diseases
   Perusek, Lindsay, Maeda, Tadao · 2013 · Nutrients
8. Gene Therapy Using a <i>miniCEP290</i> Fragment Delays Photoreceptor Degeneration in a Mouse Model of Leber Congenital Amaurosis
   Zhang, Wei, Li, Linjing, Su, Qin, Gao, Guangping, Khanna, Hemant · 2018 · Human Gene Therapy
9. MicroRNA-Restricted Transgene Expression in the Retina
   Karali, Marianthi, Manfredi, Anna, Puppo, Agostina, Marrocco, Elena, Gargiulo, Annagiusi, Allocca, Mariacarmela, Corte, Michele Della, Rossi, Settimio, Giunti, Massimo, Bacci, Maria Laura et al. · 2011 · PLoS ONE
10. Retinal tropism and transduction of adeno-associated virus varies by serotype and route of delivery (intravitreal, subretinal, or suprachoroidal) in rats
    Han, Ian C., Cheng, Justine L., Burnight, Erin R., Ralston, Christy L., Fick, Jessica L., Thomsen, Gabriella J., Tovar, Emilio F., Russell, Stephen R., Sohn, Elliott H., Mullins, Robert F. et al. · 2020 · Human Gene Therapy
11. Two novel CRX mutant proteins causing autosomal dominant Leber congenital amaurosis interact differently with NRL
    Lorenzo Nichols, Ramakrishna P. Alur, Elangovan Boobalan, Yuri V. Sergeev, Rafael C. Caruso, Edwin M. Stone, Anand Swaroop, Mary A. Johnson, Brian P. Brooks · 2010 · Human Mutation
12. Dog Models for Blinding Inherited Retinal Dystrophies
    Simon Michael Petersen‐Jones, András M. Komáromy · 2015 · Human Gene Therapy Clinical Development
13. rAAV Human Trial Experience
    Katherine A. High, Patrick R. Aubourg · 2011 · Methods in molecular biology
14. Correct mRNA Processing at a Mutant TT Splice Donor in FANCC Ameliorates the Clinical Phenotype in Patients and Is Enhanced by Delivery of Suppressor U1 snRNAs
    Linda Hartmann, Kornelia Neveling, Stephanie Borkens, Hildegard Schneider, Marcel Freund, Elke Grassman, Stephan Theiss, Angela Wawer, Stefan E.G. Burdach, Arleen D. Auerbach et al. · 2010 · The American Journal of Human Genetics
15. Gene Therapy for Choroideremia Using an Adeno-Associated Viral (AAV) Vector
    Alun R. Barnard, Markus Groppe, Robert Edward MacLaren · 2014 · Cold Spring Harbor Perspectives in Medicine
16. Subretinal delivery of adeno-associated virus serotype 2 results in minimal immune responses that allow repeat vector administration in immunocompetent mice
    Barker, Susie E., Broderick, Cathryn A., Robbie, Scott J., Duran, Yanai, Natkunarajah, Mythili, Buch, Prateek, Balaggan, Kamaljit S., MacLaren, Robert E., Bainbridge, James W. B., Smith, Alexander J. et al. · 2009 · The Journal of Gene Medicine
17. Voretigene neparvovec-rzyl for treatment of <i>RPE65</i>-mediated inherited retinal diseases: a model for ocular gene therapy development
    Ciulla, Thomas A., Hussain, Rehan M., Berrocal, Audina M., Nagiel, Aaron · 2020 · Expert Opinion on Biological Therapy
18. AAV for Gene Therapy in Ocular Diseases: Progress and Prospects
    Xiaoyu He, Yidian Fu, Liang Ma, Yizheng Yao, Shengfang Ge, Zhi Hua Yang, Xianqun Fan · 2023 · Research
19. Mutation Discovered in a Feline Model of Human Congenital Retinal Blinding Disease
    Marilyn A. Menotti-Raymond, Koren Holland Deckman, Victor A. David, Jaimie L Myrkalo, Stephen J. O’Brien, Kristina L. Narfström · 2010 · Investigative Ophthalmology & Visual Science
20. AAV-Mediated Gene Therapy in the Guanylate Cyclase (RetGC1/RetGC2) Double Knockout Mouse Model of Leber Congenital Amaurosis
    Sanford L. Boye, Igor V. Peshenko, Wei Huang, Seok-Hong Min, Issam McDoom, Christine Nichols Kay, Xuan Liu, Frank M. Dyka, Thomas C. Foster, Yumiko Umino et al. · 2012 · Human Gene Therapy
21. Electrospun nanofibrous scaffolds for controlled release of adeno-associated viral vectors
    Slgirim Lee, Jung‐Suk Kim, Hun Su Chu, Go-Woon Kim, Jong‐In Won, Jae‐Hyung Jang · 2011 · Acta Biomaterialia
22. Animal models and different therapies for treatment of retinitis pigmentosa.
    Miren Agurtzane Rivas, Elena Vecino · 2009 · PubMed
23. Biophysical Properties of Optogenetic Tools and Their Application for Vision Restoration Approaches
    Simon D. Klapper, Anka Swiersy, Ernst Bamberg, Volker Busskamp · 2016 · Frontiers in Systems Neuroscience
24. Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human Retina
    Maria Inês Patrício, Alun R. Barnard, Harry O. Orlans, Michelle E. McClements, Robert Edward MacLaren · 2017 · Molecular Therapy — Nucleic Acids
25. Gene therapy and the adeno‐associated virus in the treatment of genetic and acquired ophthalmic diseases in humans: Trials, future directions and safety considerations
    Charmaine A. Ramlogan‐Steel, Aparna Murali, Sławomir Andrzejewski, Bijay P. Dhungel, Jason C. Steel, Christopher J. Layton · 2018 · Clinical and Experimental Ophthalmology
26. Contemporary approaches to visual prostheses
    Mirochnik, Rebecca M., Pezaris, John S. · 2019 · Military Medical Research
27. Gene therapy matures in the clinic
    Leonard William Seymour, Adrian James Thrasher · 2012 · Nature Biotechnology
28. Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities
    Yueh Chien, Yu‐Jer Hsiao, Shih‐Jie Chou, Ting-Yi Lin, Aliaksandr A. Yarmishyn, Weiyi Lai, Meng‐Shiue Lee, Yi‐Ying Lin, Tzu-Wei Lin, De‐Kuang Hwang et al. · 2022 · Journal of Nanobiotechnology
29. Controlling Brain Cells With Light: Ethical Considerations for Optogenetic Clinical Trials
    Frédéric Gilbert, Alexander R. Harris, Robert M. I. Kapsa · 2014 · AJOB Neuroscience
30. Gene supplementation therapy for recessive forms of inherited retinal dystrophies
    Alexander J. Smith, James W. Bainbridge, Robin R. Ali · 2011 · Gene Therapy
31. Chromatic Pupillometry Dissects Function of the Three Different Light-Sensitive Retinal Cell Populations in RPE65 Deficiency
    Birgit Lorenz, Elisabeth Strohmayr, Steffen Zahn, Christoph Friedburg, Martin Kramer, Markus N. Preising, Knut Stieger · 2012 · Investigative Ophthalmology & Visual Science
32. The physiological impact of microRNA gene regulation in the retina
    Thomas R. Sundermeier, Krzysztof Palczewski · 2012 · Cellular and Molecular Life Sciences
33. Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells
    Binbin Cheng, C Ling, Y Dai, Yuan Lu, L. G. Glushakova, Samantha W.Y. Gee, Katherine E. McGoogan, George Aslanidi, Morag Park, Peter W. Stacpoole et al. · 2011 · Gene Therapy
34. CRB1 : One Gene, Many Phenotypes
    Miriam Ehrenberg, Eric A. Pierce, Gerald F. Cox, Anne B. Fulton · 2013 · Seminars in Ophthalmology
35. Host immune responses after suprachoroidal delivery of AAV8 in nonhuman primate eyes
    Chung, Sook Hyun, Mollhoff, Iris Natalie, Mishra, Alaknanda, Sin, Tzu-Ni, Ngo, Taylor, Ciulla, Thomas, Sieving, Paul, Thomasy, Sara M., Yiu, Glenn · 2021 · Human Gene Therapy
36. Long-Term Effects of In Vivo Genome Editing in the Mouse Retina Using Campylobacter jejuni Cas9 Expressed via Adeno-Associated Virus
    Jo, Dong Hyun, Koo, Taeyoung, Cho, Chang Sik, Kim, Jin Hyoung, Kim, Jin-Soo, Kim, Jeong Hun · 2019 · Molecular Therapy
37. The gene therapy journey for hemophilia: are we there yet?
    Katherine A. High · 2012 · Blood
38. Low Vision and Plasticity: Implications for Rehabilitation
    Gordon E. Legge, Susana T. L. Chung · 2016 · Annual Review of Vision Science
39. Two-photon microscopy reveals early rod photoreceptor cell damage in light-exposed mutant mice
    Akiko Maeda, Grażyna Palczewska, Marcin Golczak, Hideo Kohno, Zhiqian Dong, Tadao Maeda, Krzysztof Palczewski · 2014 · Proceedings of the National Academy of Sciences
40. Retinal Ganglion Cell Gene Therapy and Visual System Repair
    Mats Hellström, Alan R. Harvey · 2011 · Current Gene Therapy
41. Nanocarriers of nanotechnology in retinal diseases
    Ali M. Al-Halafi · 2014 · Saudi Journal of Ophthalmology
42. Synthesis and Characterization of Glycol Chitosan DNA Nanoparticles for Retinal Gene Delivery
    Rajendra Narayan Mitra, Zongchao Han, Miles J. Merwin, Muhammed Al Taai, Shannon M. Conley, Muna I. Naash · 2013 · ChemMedChem
43. Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction
    James William Yockman, Andrew S. Kastenmeier, Harold M. Erickson, Jonathan G. Brumbach, Matthew G. Whitten, Aida Albanil, Dean Y. Li, Sung Wan Kim, David A. Bull · 2008 · Journal of Controlled Release
44. Development of next generation adeno-associated viral vectors capable of selective tropism and efficient gene delivery
    Chuanling Zhang, Tianzhuo Yao, Yongxiang Zheng, Zhongjun Li, Qiang Zhang, Lihe Zhang, Demin Zhou · 2015 · Biomaterials
45. Prevailing Public Perceptions of the Ethics of Gene Therapy
    Julie M. Robillard, Dylan Roskams-Edris, Boris Kuzeljevic, Judy Illes · 2014 · Human Gene Therapy
46. Therapeutic strategy to rescue mutation-induced exon skipping in rhodopsin by adaptation of U1 snRNA
    Gaby Tanner, Esther Glaus, Daniel Barthelmes, Marius Ader, Johannes C. Fleischhauer, Franco Pagani, Wolfgang Berger, John Neidhardt · 2008 · Human Mutation
47. Task-Dependent V1 Responses in Human Retinitis Pigmentosa
    Yoichiro Masuda, Hiroshi Horiguchi, Serge Olaf Dumoulin, Ayumu Furuta, Satoru Miyauchi, Satoshi Nakadomari, Brian Arie Wandell · 2010 · Investigative Ophthalmology & Visual Science
48. Adeno-Associated Virus-Mediated Rhodopsin Replacement Provides Therapeutic Benefit in Mice with a Targeted Disruption of the Rhodopsin Gene
    Arpad Palfi, Sophia Millington‐Ward, Naomi Chadderton, Mary O’Reilly, Tobias Goldmann, Marian M. Humphries, Tiansen Li, Uwe Wolfrum B, Peter Humphries, Paul F. Kenna et al. · 2009 · Human Gene Therapy
49. Mesenchymal stem cells, cancer challenges and new directions
    Nedime Serakıncı, Umut Fahrioğlu, Rikke Christensen · 2014 · European Journal of Cancer
50. Gene therapy provides long-term visual function in a pre-clinical model of retinitis pigmentosa
    Katherine J. Wert, R. J. Davis, Javier Sancho-Pellúz, Patsy M. Nishina, Stephen H. Tsang · 2012 · Human Molecular Genetics
51. Latest developments in the large-scale production of adeno-associated virus vectors in insect cells toward the treatment of neuromuscular diseases
    Lionel Galibert, Otto‐Wilhelm Merten · 2011 · Journal of Invertebrate Pathology
52. Patients and animal models of CNGβ1-deficient retinitis pigmentosa support gene augmentation approach
    Simon Michael Petersen‐Jones, Laurence Mireille Occelli, Paige A. Winkler, Winston Lee, Janet R. Sparrow, Mai Tsukikawa, Sanford L. Boye, Vince A. Chiodo, Jenina E. Capasso, Elvir Bećirović et al. · 2017 · Journal of Clinical Investigation
53. Restoring the natural tropism of AAV2 vectors for human liver
    Marti Cabanes‐Creus, Claus V. Hallwirth, Adrian Westhaus, Boaz H. Ng, Sophia H.Y. Liao, Erhua Zhu, Renina Gale Navarro, Grober Baltazar, Matthieu Drouyer, Suzanne Scott et al. · 2020 · Science Translational Medicine
54. Dual <i>ABCA4</i> -AAV Vector Treatment Reduces Pathogenic Retinal A2E Accumulation in a Mouse Model of Autosomal Recessive Stargardt Disease
    Dyka, Frank M., Molday, Laurie L., Chiodo, Vince A., Molday, Robert S., Hauswirth, William W. · 2019 · Human Gene Therapy
55. Reduction of choroidal neovascularization in mice by adeno‐associated virus‐delivered anti‐vascular endothelial growth factor short hairpin RNA
    Anne Louise Askou, Jean-Antoine C. Pournaras, Maria Pihlmann Kristensen, Jesper Dyrendom Svalgaard, Yvan Arsenijévic, Corinne Kostic, Toke Bek, Frederik Dagnæs‐Hansen, Jacob Giehm Mikkelsen, Thomas Gryesten Jensen et al. · 2012 · The Journal of Gene Medicine
56. Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates
    C-M Lai, Marie J. Estcourt, Robyn P. Himbeck, S-Y Lee, I Yeo, Chi D. Luu, Boon Kwang Loh, M W Lee, Veluchamy A. Barathi, Jason Villano et al. · 2011 · Gene Therapy
57. Post-Injury Delivery of rAAV2-CNTF Combined with Short-Term Pharmacotherapy Is Neuroprotective and Promotes Extensive Axonal Regeneration after Optic Nerve Trauma
    Mats Hellström, Margaret A. Pollett, Alan R. Harvey · 2011 · Journal of Neurotrauma
58. A new technique for controlling the brain: optogenetics and its potential for use in research and the clinic
    Ryan T. LaLumiere · 2010 · Brain stimulation
59. Tyrosine-Mutant AAV8 Delivery of Human MERTK Provides Long-Term Retinal Preservation in RCS Rats
    Wen‐Tao Deng, Astra Dinculescu, Qiuhong Li, Sanford L. Boye, Jie Li, Marina S. Gorbatyuk, Jijing Pang, Vince A. Chiodo, Michael T. Matthes, Douglas Yasumura et al. · 2012 · Investigative Ophthalmology & Visual Science
60. Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination
    Andrea Coluccio, Francesca Miselli, Angelo Lombardo, Alessandra Marconi, Guidantonio Malagoli Tagliazucchi, Manuel A.F.V. Gonçalves, Carlo Pincelli, Giulietta Maruggi, Marcela Del Río, Luigi Naldini et al. · 2013 · Molecular Therapy
61. Site‐Specific Modification of Adeno‐Associated Viruses via a Genetically Engineered Aldehyde Tag
    Yarong Liu, Yun Hua Fang, Yu Zhou, Ebrahim Zandi, Chi-Lin Lee, Kye‐Il Joo, Pin Wang · 2012 · Small
62. AAV-Mediated Gene Augmentation Therapy Restores Critical Functions in Mutant PRPF31+/− iPSC-Derived RPE Cells
    Elizabeth M. Brydon, Revital Bronstein, Adriana Buskin, Majlinda Lako, Eric A. Pierce, Rosario Fernández‐Godino · 2019 · Molecular Therapy — Methods & Clinical Development
63. Pristimerin enhances recombinant adeno-associated virus vector-mediated transgene expression in human cell lines in vitro and murine hepatocytes in vivo
    Li-Na Wang, Yuan Wang, Yuan Lu, Zi-fei Yin, Yuan-hui Zhang, George Aslanidi, Arun Srivastava, Changquan Ling, Chen Ling · 2014 · Journal of Chinese Integrative Medicine
64. Polymer coatings for delivery of nucleic acid therapeutics
    Richard Laga, Robert C. Carlisle, Mark Tangney, Karel Ulbrich, Leonard William Seymour · 2012 · Journal of Controlled Release
65. Gene-based therapies for dominantly inherited retinopathies
    Gwyneth Jane Farrar, Sophia Millington‐Ward, Naomi Chadderton, Peter Humphries, Paul F. Kenna · 2011 · Gene Therapy
66. High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo
    Liujiang Song, Xiaomiao Li, Giridhara Rao Jayandharan, Yuan Wang, George Aslanidi, Chen Ling, Zhong Li, Guangping Gao, Mervin C. Yöder, Changquan Ling et al. · 2013 · PLoS ONE
67. Three-dimensional early retinal progenitor 3D tissue constructs derived from human embryonic stem cells
    Gabriel Nistor, Magdalene J. Seiler, Fengrong Yan, David J. P. Ferguson, Hans S. Keirstead · 2010 · Journal of Neuroscience Methods
68. AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage
    Christopher Binny, Jenny McIntosh, Marco Della Peruta, Hanna Kymäläinen, Edward G. D. Tuddenham, Suzanne M. K. Buckley, Simon N. Waddington, John H. McVey, Yunyu Spence, Christopher L. Morton et al. · 2011 · Blood
69. Optogenetic Approaches to Restoring Vision
    Zhuo‐Hua Pan, Qi Lu, Anding Bi, Alexander M. Dizhoor, Gary W. Abrams · 2015 · Annual Review of Vision Science
70. The Skeletal Muscle Environment and Its Role in Immunity and Tolerance to AAV Vector-Mediated Gene Transfer
    Florence Boisgérault, Federico Mingozzi · 2015 · Current Gene Therapy
71. Gene Therapy in a Large Animal Model of PDE6A-Retinitis Pigmentosa
    Freya M. Mowat, Laurence Mireille Occelli, Joshua T. Bartoe, Kristen J. Gervais, Ashlee R. Bruewer, Janice R. Querubin, Astra Dinculescu, Sanford L. Boye, William W. Hauswirth, Simon Michael Petersen‐Jones · 2017 · Frontiers in Neuroscience
72. A novel MERTK deletion is a common founder mutation in the Faroe Islands and is responsible for a high proportion of retinitis pigmentosa cases.
    Elsebet Østergaard, Morten Dunø, Mustafa Batbayli, Kaj Vilhelmsen, Thomas Rosenberg · 2011 · Europe PMC (PubMed Central)
73. Recombinant Adeno-Associated Viral Vector Production and Purification
    Jin‐Hong Shin, Yongping Yue, Dongsheng Duan · 2011 · Methods in molecular biology
74. Immune barriers to successful gene therapy
    Te-Lang Wu, Hildegund C.J. Ertl · 2008 · Trends in Molecular Medicine
75. Assessment of Tropism and Effectiveness of New Primate-Derived Hybrid Recombinant AAV Serotypes in the Mouse and Primate Retina
    Charbel Issa, Peter, De Silva, Samantha R., Lipinski, Daniel M., Singh, Mandeep S., Mouravlev, Alexandre, You, Qisheng, Barnard, Alun R., Hankins, Mark W., During, Matthew J., MacLaren, Robert E. · 2013 · PLoS ONE
76. The Future Looks Brighter After 25 Years of Retinal Gene Therapy
    Alberto Auricchio, Alexander J. Smith, Robin R. Ali · 2017 · Human Gene Therapy
77. Strategies to package recombinant Adeno-Associated Virus expressing the N-terminal gasdermin domain for tumor treatment
    Yuan Lu, Wenbo He, Xin Huang, Yu He, Xiaojuan Gou, Xiaoke Liu, Zhe Hu, Weize Xu, Khaista Rahman, Shan Li et al. · 2021 · Nature Communications
78. AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins
    Anastasios Georgiadis, Marion Tschernutter, James W. Bainbridge, Scott J. Robbie, Jenny McIntosh, Amit Chunilal Nathwani, Alexander J. Smith, Robin R. Ali · 2009 · Gene Therapy
79. The genetic profile of Leber congenital amaurosis in an Australian cohort
    Jennifer A. Thompson, John N. De Roach, Terri L. McLaren, Hannah E. Montgomery, Ling Hoffmann, Isabella Campbell, Fred Kuanfu Chen, David Anthony Mackey, Tina M. Lamey · 2017 · Molecular Genetics & Genomic Medicine
80. Humoral immune responses to <scp>AAV</scp> gene therapy in the ocular compartment
    Whitehead, Michael, Osborne, Andrew, Yu‐Wai‐Man, Patrick, Martin, Keith · 2021 · Biological Reviews
81. Gene therapy in animal models of autosomal dominant retinitis pigmentosa.
    Brian P. Rossmiller, Haoyu Mao, Alfred S. Lewin · 2012 · PubMed Central
82. Self-complementary AAV5 vector facilitates quicker transgene expression in photoreceptor and retinal pigment epithelial cells of normal mouse
    Fansheng Kong, Wensheng Li, Xia Li, Qinxiang Zheng, Xufeng Dai, Xiangtian Zhou, Sanford L. Boye, William W. Hauswirth, Jia Qu, Jijing Pang · 2010 · Experimental Eye Research
83. Gene Therapy in Ophthalmology: Validation on Cultured Retinal Cells and Explants from Postmortem Human Eyes
    Mathias Fradot, Volker Busskamp, Valérie Forster, Thérèse Cronin, Thierry Léveillard, Jean Bennett, José‐Alain Sahel, Botond Roska, Serge A. Picaud · 2010 · Human Gene Therapy
84. Improvement of Visual Performance With Intravitreal Administration of 9-cis-Retinal in Rpe65-Mutant Dogs
    Patricia M. Gearhart · 2010 · Archives of Ophthalmology
85. Current Concepts in the Treatment of Retinitis Pigmentosa
    Maria A. Musarella, Ian M. MacDonald · 2010 · Journal of Ophthalmology
86. Multigenic lentiviral vectors for combined and tissue-specific expression of miRNA- and protein-based antiangiogenic factors
    Anne Louise Askou, Lars Aagaard, Corinne Kostic, Yvan Arsenijévic, Anne Kruse Hollensen, Toke Bek, Thomas Gryesten Jensen, Jacob Giehm Mikkelsen, Thomas J. Corydon · 2015 · Molecular Therapy — Methods & Clinical Development
87. A Large Animal Model for CNGB1 Autosomal Recessive Retinitis Pigmentosa
    Paige A. Winkler, Kari J. Ekenstedt, Laurence Mireille Occelli, Anton V. Frattaroli, Joshua T. Bartoe, Patrick J. Venta, Simon Michael Petersen‐Jones · 2013 · PLoS ONE
88. Gene and cell therapy for children — New medicines, new challenges?
    Karen F. Buckland, Hubert Bobby Gaspar · 2014 · Advanced Drug Delivery Reviews
89. Gene Expression Profiling of the Retina after Transcorneal Electrical Stimulation in Wild-type Brown Norway Rats
    Gabriel Willmann, Karin Schäferhoff, Manuel Dominik Fischer, Blanca Arango‐González, Sylvia Bolz, Lubka Naycheva, Tobias Röck, Michael von Bonin, Karl Ulrich Bartz‐Schmidt, Eberhart Zrenner et al. · 2011 · Investigative Ophthalmology & Visual Science
90. Effective Dynamic Range and Retest Reliability of Dark-Adapted Two-Color Fundus-Controlled Perimetry in Patients With Macular Diseases
    Maximilian Pfau, Moritz Lindner, Philipp L. Müller, Johannes Birtel, Robert Patrick Finger, Wolf M. Harmening, Monika Fleckenstein, Frank Gerhard Holz, Steffen Schmitz-Valckenberg · 2017 · Investigative Ophthalmology & Visual Science
91. AAV serotype influences gene transfer in corneal stroma in vivo
    Ajay Sharma, Jonathan C. K. Tovey, Arkasubhra Ghosh, Rajiv R. Mohan · 2010 · Experimental Eye Research
92. Has retinal gene therapy come of age? From bench to bedside and back to bench
    Ivana Trapani, Alberto Auricchio · 2019 · Human Molecular Genetics
93. A mutation in gene CNGA3 is associated with day blindness in sheep
    Shay Reicher, Eyal Seroussi, E. Gootwine · 2009 · Genomics
94. Combined Paracrine and Endocrine AAV9 mediated Expression of Hepatocyte Growth Factor for the Treatment of Renal Fibrosis
    Stephanie Schievenbusch, Ingo Strack, Melanie Scheffler, Roswitha Nischt, Oliver Coutelle, Marianna Hösel, Michael J. Hallek, J. Fries, Hans‐Peter Dienes, Margarete Odenthal et al. · 2010 · Molecular Therapy
95. BEST1: the Best Target for Gene and Cell Therapies
    Tingting Yang, Sally Justus, Yao Li, Stephen H. Tsang · 2015 · Molecular Therapy
96. Pharmacotherapy of retinal disease with visual cycle modulators
    Rehan M. Hussain, Ninel Z. Gregori, Thomas A. Ciulla, Byron L. Lam · 2018 · Expert Opinion on Pharmacotherapy
97. Vector engineering, strategies and targets in cancer gene therapy
    Vijayata Singh, Nusrat Khan, Giridhara Rao Jayandharan · 2021 · Cancer Gene Therapy
98. Treatment of a retinal dystrophy, fundus albipunctatus, with oral 9-cis- -carotene
    Rotenstreich, Y., Harats, D., Shaish, A., Pras, E., Belkin, M. · 2010 · British Journal of Ophthalmology
99. Optimization of AAV vectors to target persistent viral reservoirs
    Colón-Thillet, Rossana, Jerome, Keith R., Stone, Daniel · 2021 · Virology Journal
100. Enhancement of adeno-associated virus-mediated gene therapy using hydroxychloroquine in murine and human tissues
     Chandler, Laurel C., Barnard, Alun R., Caddy, Sarah L., Patrício, Maria I., McClements, Michelle E., Fu, Howell, Rada, Cristina, MacLaren, Robert E., Xue, Kanmin · 2019 · Molecular Therapy - Methods &amp; Clinical Development